Sidley Austin LLP advised Alphamab Oncology (HKEX: 9966) as the Hong Kong and U.S. legal adviser in its HK$1.83 billion (approximately US$234 million) initial public offering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
